These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4578357)

  • 1. [Treatment of dysfunctions of the temporomandibular joint with thiocolchicoside].
    Sandner O
    An Esp Odontoestomatol; 1973; 32(4):337-46. PubMed ID: 4578357
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of temporomandibular joint dysfunctions with thiocolchicoside].
    Sandner O
    Acta Odontol Venez; 1971 Dec; 9(3):193-204. PubMed ID: 5293307
    [No Abstract]   [Full Text] [Related]  

  • 3. Gout of the temporomandibular joint. Report of three cases.
    Kleinman HZ; Ewbank RL
    Oral Surg Oral Med Oral Pathol; 1969 Feb; 27(2):281-2. PubMed ID: 5249526
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of temporomandibular joint dysfunction].
    Igarashi H
    Jibiinkoka; 1965 Nov; 37(11):1089-94. PubMed ID: 5893334
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacological methods applied to temporomandibular dysfunctions].
    Martins E; Mainieri ET
    Rev Gaucha Odontol; 1972; 20(4):274-7. PubMed ID: 4515451
    [No Abstract]   [Full Text] [Related]  

  • 6. Topical versus systemic diclofenac in the treatment of temporo-mandibular joint dysfunction symptoms.
    Di Rienzo Businco L; Di Rienzo Businco A; D'Emilia M; Lauriello M; Coen Tirelli G
    Acta Otorhinolaryngol Ital; 2004 Oct; 24(5):279-83. PubMed ID: 15871609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging role of botulinum toxin in the treatment of temporomandibular disorders.
    Song PC; Schwartz J; Blitzer A
    Oral Dis; 2007 May; 13(3):253-60. PubMed ID: 17448205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of synthetic corticosteroids on the level of the temporomandibular joint. (Clinical contribution--distant controls)].
    Martani F; Cuppini A; Gelli M
    Mondo Odontostomatol; 1968; 10(5):574-82. PubMed ID: 5247338
    [No Abstract]   [Full Text] [Related]  

  • 9. [Care of the patient with temporomandibular joint syndrome].
    McNeill C
    Inf Orthod Kieferorthop; 1980; 12(4):433-50. PubMed ID: 6939673
    [No Abstract]   [Full Text] [Related]  

  • 10. Joint treatment.
    SAAD Dig; 1977 Jul; 3(7):150. PubMed ID: 276088
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dexamethasone in dysfunctions of the temporomandibular joint. Preliminary note with 50 cases].
    Volinier RM; Bianchi DH
    An Esp Odontoestomatol; 1967; 26(4):314-8. PubMed ID: 5274002
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of hyaluronic acid in the temporomandibular joint and its therapeutic significance].
    Gu Z; Fang Y; Wu Q; Xie Z
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Nov; 31(6):381-3. PubMed ID: 9592300
    [No Abstract]   [Full Text] [Related]  

  • 13. Diazepam in the treatment of temporomandibular joint dysfunction syndrome--a double blind study.
    Jagger RG
    J Dent; 1973 Oct; 2(1):37-40. PubMed ID: 4592044
    [No Abstract]   [Full Text] [Related]  

  • 14. Experience in surgical treatment of temporomandibular joint arthrosis by the Ward-technique.
    Sada V
    Trans Int Conf Oral Surg; 1967; ():265-7. PubMed ID: 5237074
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical use of "Muscarum" in temporomandibular joint syndrome].
    Shirakawa M; Uzawa S; Shizume M; Wade H; Nakajima T
    Shikai Tenbo; 1979; 53(3):517-20. PubMed ID: 295974
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnosis and management of temporomandibular joint dysfunction syndrome in the field of oral surgery].
    Takenoshita Y
    Hotetsu Rinsho; 1981; (Special Issue):221-32. PubMed ID: 6943531
    [No Abstract]   [Full Text] [Related]  

  • 17. [Administration of drops into the temporomandibular joint].
    Egorov PM
    Stomatologiia (Mosk); 1975; 54(5):99-100. PubMed ID: 1061339
    [No Abstract]   [Full Text] [Related]  

  • 18. Temporomandibular joint syndrome: influence of the first symptom on the initial therapeutic response.
    Carraro JJ; Caffesse RG; Albano E
    J Prosthet Dent; 1973 Jul; 30(1):87-90. PubMed ID: 4575210
    [No Abstract]   [Full Text] [Related]  

  • 19. Double-blind clinical study of Piroxicam as adjuvant in the treatment of the pain and dysfunction of the temporomandibular joints.
    van den Berghe LI; de Boever JA; Schautteet H
    Cranio; 1986 Oct; 4(4):351-6. PubMed ID: 3536136
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of botulinum toxin for the treatment of temporomandibular disorder.
    Freund B; Schwartz M
    Oral Health; 1998 Feb; 88(2):32-7. PubMed ID: 9610334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.